# Boston Scientific vs Edwards Lifesciences: stocks compared

URL: https://funkfolio.com/compare/bsx-vs-ew

> Boston Scientific ($62.4B, P/E 18.2) and Edwards Lifesciences ($60.6B, P/E 61.3) compared: size, valuation, margins, debt, cash and price change.

---

## Boston Scientific vs Edwards Lifesciences

Boston Scientific (BSX), health care, and Edwards Lifesciences (EW), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Boston Scientific is worth $62.4B on the stock market and Edwards Lifesciences $60.6B: Boston Scientific is valued at 3% more. Boston Scientific trades at 18.2 times earnings and Edwards Lifesciences at 61.3; operating margins in their latest fiscal years were 18.0% and 20.8%. Over the past year Boston Scientific's share price has moved -56.0% and Edwards Lifesciences's +27.5%.

### Key facts

- **Boston Scientific market value:** $62.4B
- **Edwards Lifesciences market value:** $60.6B
- **Boston Scientific P/E:** 18.2
- **Edwards Lifesciences P/E:** 61.3
- **Boston Scientific revenue:** $20.1B FY to 2025-12-31
- **Edwards Lifesciences revenue:** $6.1B FY to 2025-12-31
- **Superinvestors holding both:** 2

Market values as of 18 Nov 2026, 02:25 UTC.

Boston Scientific vs Edwards Lifesciences: every measure side by side

| Measure | Boston Scientific | Edwards Lifesciences |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $62.4B higher | $60.6B lower |
| Revenue | $20.1B higher | $6.1B lower |
| Earnings | $2.9B higher | $1.1B lower |
| Employees | 59,000 higher | 16,000 lower |
| Total assets | $43.7B higher | $13.7B lower |
| Valuation |  |  |
| P/E | 18.2 lower | 61.3 higher |
| P/S | 3.1 lower | 10.0 higher |
| P/B | 2.4 lower | 5.6 higher |
| Dividend yield | 0.00% | 0.00% |
| Profitability |  |  |
| Operating margin | 18.0% lower | 20.8% higher |
| Balance sheet |  |  |
| Net assets | $24.2B higher | $10.3B lower |
| Total liabilities | $19.2B higher | $3.4B lower |
| Total debt | $11.4B higher | $598.3M lower |
| Cash on hand | $2B lower | $2.9B higher |
| Price change |  |  |
| Today | -1.51% higher | -1.57% lower |
| 1 year | -56.0% lower | +27.5% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Boston Scientific 42.3, Edwards Lifesciences 124.4.

- Boston Scientific (BSX)
- Edwards Lifesciences (EW)

Boston Scientific and Edwards Lifesciences share prices over one year, rebased to 100: Boston Scientific ends at 42.3, Edwards Lifesciences at 124.4.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | BSX | EW |
| --- | --- | --- |
| Nov 28, 2025 | 99.8 | 102.3 |
| Dec 31, 2025 | 93.7 | 100.6 |
| Jan 30, 2026 | 91.9 | 96.0 |
| Feb 27, 2026 | 75.5 | 102.0 |
| Mar 31, 2026 | 61.7 | 94.5 |
| Apr 30, 2026 | 56.6 | 98.5 |
| May 29, 2026 | 47.5 | 102.0 |
| Jun 30, 2026 | 41.9 | 106.8 |
| Jul 31, 2026 | 45.9 | 101.6 |
| Aug 31, 2026 | 47.5 | 107.1 |
| Sep 30, 2026 | 42.9 | 101.9 |
| Oct 30, 2026 | 41.3 | 108.6 |
| Nov 17, 2026 | 42.3 | 124.4 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (2)

- [Primecap team](https://funkfolio.com/gurus/primecap) 1.6% / 0.2%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.1% / 0.2%

#### Boston Scientific only (11)

- [Andrew Spokes](https://funkfolio.com/gurus/farallon) 2.6%
- [Lee Ainslie](https://funkfolio.com/gurus/lee-ainslie) 2.3%
- [Steven Romick](https://funkfolio.com/gurus/steven-romick) 1.2%
- [Louis Bacon](https://funkfolio.com/gurus/louis-bacon) 0.8%
- [David Shaw (founder)](https://funkfolio.com/gurus/david-shaw) 0.7%
- [John Overdeck and David Siegel (founders)](https://funkfolio.com/gurus/two-sigma) 0.6%
- [Sarah Ketterer](https://funkfolio.com/gurus/sarah-ketterer) 0.4%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 0.3%
- [Temasek](https://funkfolio.com/gurus/temasek) 0.3%
- [Paul Tudor Jones](https://funkfolio.com/gurus/paul-tudor-jones) 0.3%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 0.1%

#### Edwards Lifesciences only (7)

- [David Rolfe](https://funkfolio.com/gurus/david-rolfe) 3.1%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) 1.6%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.7%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.2%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2%
- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 0.1%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Boston Scientific / Edwards Lifesciences). [Who owns BSX](https://funkfolio.com/stock/BSX/superinvestors) · [Who owns EW](https://funkfolio.com/stock/EW/superinvestors)

### More on Boston Scientific

- [Boston Scientific (BSX) stock page](https://funkfolio.com/stock/BSX)
- [Boston Scientific market cap](https://funkfolio.com/stock/BSX/market-cap)
- [Boston Scientific revenue](https://funkfolio.com/stock/BSX/revenue)
- [Boston Scientific P/E ratio](https://funkfolio.com/stock/BSX/pe-ratio)
- [Boston Scientific operating margin](https://funkfolio.com/stock/BSX/operating-margin)
- [Boston Scientific total debt](https://funkfolio.com/stock/BSX/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Edwards Lifesciences

- [Edwards Lifesciences (EW) stock page](https://funkfolio.com/stock/EW)
- [Edwards Lifesciences market cap](https://funkfolio.com/stock/EW/market-cap)
- [Edwards Lifesciences revenue](https://funkfolio.com/stock/EW/revenue)
- [Edwards Lifesciences P/E ratio](https://funkfolio.com/stock/EW/pe-ratio)
- [Edwards Lifesciences operating margin](https://funkfolio.com/stock/EW/operating-margin)
- [Edwards Lifesciences total debt](https://funkfolio.com/stock/EW/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Boston Scientific against its closest peers

- [Boston Scientific vs Cardinal Health](https://funkfolio.com/compare/bsx-vs-cah)
- [Boston Scientific vs Cencora](https://funkfolio.com/compare/bsx-vs-cor)
- [Boston Scientific vs Takeda Pharmaceutical](https://funkfolio.com/compare/bsx-vs-tak)
- [Boston Scientific vs argenx](https://funkfolio.com/compare/argx-vs-bsx)

#### Edwards Lifesciences against its closest peers

- [Edwards Lifesciences vs argenx](https://funkfolio.com/compare/argx-vs-ew)
- [Edwards Lifesciences vs Becton, Dickinson](https://funkfolio.com/compare/bdx-vs-ew)
- [Edwards Lifesciences vs Cardinal Health](https://funkfolio.com/compare/cah-vs-ew)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Boston Scientific or Edwards Lifesciences?**

By market value, Boston Scientific is the larger: $62.4B against $60.6B for Edwards Lifesciences. By revenue in its latest fiscal year, Boston Scientific is the larger: $20.1B against $6.1B for Edwards Lifesciences.

**Which has the higher P/E ratio?**

Edwards Lifesciences: 61.3, against 18.2 for Boston Scientific. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Edwards Lifesciences: 20.8%, against 18.0% for Boston Scientific. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Boston Scientific: $11.4B, against $598.3M for Edwards Lifesciences. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Boston Scientific and Edwards Lifesciences?**

In their latest 13F filings, Primecap team and Israel Englander hold both.

### Cite this page

Funkfolio, “Boston Scientific vs Edwards Lifesciences”, data as of 18 November 2026. https://funkfolio.com/compare/bsx-vs-ew

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
